Product Name | MF | CAS | Details |
---|
Parogrelil - NT 702, free base | NM 702 | C19H18BrClN4O2 | 139145-27-0 | Details |
NU 1025 | C9H8N2O2 | 90417-38-2 | Details |
NVP-TAE684 - TAE 684 | C30H40ClN7O3S | 761439-42-3 | Details |
Palbociclib isethionate - PD 0332991 isethionate | C26H35N7O6S | 827022-33-3 | Details |
P 22077 | C12H7F2NO3S2 | 1247819-59-5 | Details |
MJN110 | C22H21Cl2N3O4 | 1438416-21-7 | Details |
N 0425 hydrochloride - N-methyl-N-propargyl-2-aminotetralin hydrochloride | C14H18ClN | 78621-26-8 | Details |
PBTZ169 | C20H23F3N4O3S | 1377239-83-2 | Details |
NCL-00017509 | C15H12N6O | 1507367-00-1 | Details |
Paroxetine hydrochloride | C19H23ClFNO4 | 110429-35-1 | Details |
PCI 32765 - Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
P 005091 - P 5091 | C12H7Cl2NO3S2 | 882257-11-6 | Details |
ML 323 | C23H24N6 | 1572414-83-5 | Details |
ML 210 - CID 49766530 | C22H20Cl2N4O4 | 1360705-96-9 | Details |
Nolatrexed dihydrochloride - AG 337 | Thymitaq | C14H14Cl2N4OS | 152946-68-4 | Details |
PD 184352 - CI 1040 | C17H14ClF2IN2O2 | 212631-79-3 | Details |
NVP-AUY922 - VER 52296 | Luminespib | C26H31N3O5 | 747412-49-3 | Details |
OSU 03012 | C26H19F3N4O | 742112-33-0 | Details |
ONX 0914 - PR 957 | C31H40N4O7 | 960374-59-8 | Details |
OG-L002 hydrochloride | C15H16ClNO | 1357298-75-9 | Details |
ML364 | C24H18F3N3O3S2 | 1991986-30-1 | Details |
MYK-461 - Mavacamten | SAR439152 | C15H19N3O2 | 1642288-47-8 | Details |
MS 275 - Entinostat | SNDX 275 | C21H20N4O3 | 209783-80-2 | Details |
Miglitol | C8H17NO5 | 72432-03-2 | Details |
Nutlin-3a - Nutlin-3, (-)- | C30H30Cl2N4O4 | 675576-98-4 | Details |
Odiparcil - SB 424323 | GSK 424323 | C15H16O6S | 137215-12-4 | Details |
PD 98059 - NSC 679828 | C16H13NO3 | 167869-21-8 | Details |
NSC 23766 | C24H35N7 | 1177865-17-6 | Details |
MG 132 | C26H41N3O5 | 133407-82-6 | Details |
NSC 625987 | C15H13NO2S | 141992-47-4 | Details |
PD 166793 | C17H18BrNO4S | 199850-67-4 | Details |
PD 0325901 | C16H14F3IN2O4 | 391210-10-9 | Details |
Mocetinostat - MGCD 0103 | MG 0103 | C23H20N6O | 726169-73-9 | Details |
NVP 231 | C25H25N3O2S | 362003-83-6 | Details |
NQDI 1 | C19H13NO4 | 175026-96-7 | Details |
P 505-15 - PRT 062607 | C19H23N9O | 1370261-96-3 | Details |
Nutlin-3b - Nutlin-3, (+)- | C30H30Cl2N4O4 | 675576-97-3 | Details |
Mps1-IN-2 | C26H36N6O3 | 1228817-38-6 | Details |
NVP-TNKS656 - TNKS 656 | C27H34N4O5 | 1419949-20-4 | Details |
ML346 - CID 767276 | C14H12N2O4 | 100872-83-1 | Details |
MHY 908 | C17H14ClNO3S | 1393371-39-5 | Details |
Naive Stem Cell 5i inhibitor Set | Details |
NS 3694 | C15H10ClF3N2O3 | 426834-38-0 | Details |
Nutlin-3 | C30H30Cl2N4O4 | 548472-68-0 | Details |
Nelfinavir mesylate - AG 1343 | C33H49N3O7S2 | 159989-65-8 | Details |
N 0430 hydrobromide | C14H17NO2 | 96333-04-9 | Details |
MK 0822 - Odanacatib | C25H27F4N3O3S | 603139-19-1 | Details |
Palomid 529 - SG 00529 | C24H22O6 | 914913-88-5 | Details |
NVP-BGT226 - BGT 226 | C28H25F3N6O2.C4H4O4 | 1245537-68-1 | Details |
PCI 34051 | C17H16N2O3 | 950762-95-5 | Details |
Nexturastat A | C19H23N3O3 | 1403783-31-2 | Details |
ML 324 dihydrochloride | C21H24ClN3O2 | 2108968-53-0 | Details |
ONO 5334 | C21H34N4O4S | 868273-90-9 | Details |
ML348 | C18H17ClF3N3O3 | 899713-86-1 | Details |
Nilotinib - AMN 107 | Tasigna | C28H22F3N7O | 641571-10-0 | Details |
MLR 1023 - Tolimidone | CP 26154 | C11H10N2O2 | 41964-07-2 | Details |
MLN 8237 - Alisertib | C27H20ClFN4O4 | 1028486-01-2 | Details |
MLN 2238 - Ixazomib | C14H19BCl2N2O4 | 1072833-77-2 | Details |
P7C3 | C21H18Br2N2O | 301353-96-8 | Details |
NVP-BSK805 - BSK 805 | C27H28F2N6O | 1092499-93-8 | Details |
MK 5108 - VX 689 | C22H21ClFN3O3S | 1010085-13-8 | Details |
ML 355 | C21H19N3O4S2 | 1532593-30-8 | Details |
OSS-128167 | C19H14N2O6 | 887686-02-4 | Details |
MSTP | C8H8N4O3S | 2125668-23-5 | Details |
Olprinone hydrochloride - Loprinone hydrochloride | C14H11ClN4O | 119615-63-3 | Details |
Necrostatin-1 | C13H13N3OS | 4311-88-0 | Details |
PAC 1 - Procaspase activating compound 1 | C23H28N4O2 | 315183-21-2 | Details |
N 0425 hydrochloride, (-)- - N-methyl-N-propargyl-2-aminotetralin hydrochloride, (-)- | C14H17N | 98640-73-4 | Details |
MK 2206 | C25H22ClN5O | 1032350-13-2 | Details |
Nintedanib - BIBF-1120 | C31H33N5O4 | 656247-17-5 | Details |
MG 149 | C22H28O3 | 1243583-85-8 | Details |
MLN 0905 | C24H25F3N6S | 1228960-69-7 | Details |
PD 0332991 hydrochloride - Palbociclib hydrochloride | C24H30ClN7O2 | 571189-11-2 | Details |
Mitapivat | C24H26N4O3S | 1260075-17-9 | Details |
N106 | C17H14N4O3S | 862974-25-2 | Details |
NHI 2 | C17H12F3NO3 | 1269802-97-2 | Details |
PDE9A inhibitor C33(S) - (S)-C33 | C18H20ClN5O | 2066488-39-7 | Details |
Naive Stem Cell NHSM inhibitor Set - Stem Cell 6i inhibitor Set | Details |
PD 169316 | C20H13FN4O2 | 152121-53-4 | Details |
NQ301 - Compound 211 | C18H12ClNO3 | 130089-98-4 | Details |
PD 180970 | C21H15Cl2FN4O | 287204-45-9 | Details |
NVP-BKM120 - BKM 120 | C18H21F3N6O2 | 944396-07-0 | Details |
Niraparib - MK 4827 | C19H20N4O | 1038915-60-4 | Details |
MK 1775 - AZD 1775 | Adavosertib | C27H32N8O2 | 955365-80-7 | Details |
MLN 9708 - Ixazomib citrate | C20H23BCl2N2O9 | 1201902-80-8 | Details |
NSC 405020 | C12H15Cl2NO | 7497-07-6 | Details |
ME0328 | C19H19N3O2 | 1445251-22-8 | Details |
ML 351 | C15H11N3O | 847163-28-4 | Details |
PDE5 inhibitor 42 | C23H31N7O3 | 936449-28-4 | Details |
NCT-503 | C20H23F3N4S | 1916571-90-8 | Details |
NM-PP1, 1- | C20H21N5 | 221244-14-0 | Details |
N 0425 hydrochloride, (+)- - N-methyl-N-propargyl-2-aminotetralin hydrochloride, (+)- | C14H17N | 98640-74-5 | Details |
NU 7441 - KU 47788 | C25H19NO3S | 503468-95-9 | Details |
MLN 4924 - Pevonedistat | C21H25N5O4S | 905579-51-3 | Details |
N 6022 | C24H22N4O3 | 1208315-24-5 | Details |
NVP-BBD130 - BBD 130 | C28H21N5O | 853910-61-9 | Details |
NSC 687852 - b-AP15 | C22H17N3O6 | 1009817-63-3 | Details |
MHY 1485 | C17H21N7O4 | 326914-06-1 | Details |
NG 25 trihydrochloride | C29H31ClF3N5O2 | 2108554-00-1 | Details |
NSC 756093 | C20H19NO4 | 1629908-92-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 |